TIPE2 negatively regulates mycoplasma pneumonia-triggered immune response via MAPK signaling pathway

被引:0
作者
Yuanyuan Zhang
Shufen Mei
Yunlian Zhou
Dehua Yang
Ting Pan
Zhimin Chen
Qingqing Wang
机构
[1] The Children’s Hospital of Zhejiang University School of Medicine,
[2] Institute of Immunology,undefined
[3] Zhejiang University,undefined
[4] Departement of Pediatrics,undefined
[5] Red Cross Hospital of Hangzhou,undefined
来源
Scientific Reports | / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Excessive immune responses played an important role in pathophysiology of mycoplasma pneumonia (MP) infection. Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) is a negative regulator of immune response. This study investigated the expression change of TIPE2 and its role in immune defense against MP infection, as well as the underlying mechanisms. Expressions of TIPE2 both in patients and in macrophages in vitro after MP infection were measured. We further studied cytokine production and mitogen-activated protein kinase (MAPK) signaling function in macrophages with interfered expression of TIPE2 upon MP infection. A significant decrease of TIPE2 mRNA expression was observed in peripheral blood mononuclear cells (PBMCs) from MP patients, which was correlated with the severity of infection. Accordingly we found down-regulation of TIPE2 expression in macrophages after MP infection. In vitro study further suggested that TIPE2 jeopardized inflammatory cytokine production trigged by MP infection via inhibiting MAPK signaling pathway. These findings provided evidences of the novel function of TIPE2 in anti-MP immunity and its possible clinical utility related clinical significance.
引用
收藏
相关论文
共 55 条
[1]  
Michelow IC(2004)Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children Pediatrics 113 701-707
[2]  
Defilippi A(2008)Epidemiology and clinical features of Mycoplasma pneumoniae infection in children Resp Med 102 1762-1768
[3]  
Waites K(2003)New concepts of Mycoplasma pneumoniae infections in children Pediatr Pulmonol 36 267-78
[4]  
Zhang Y(2016)Cytokines as the good predictors of refractory Mycoplasma pneumonia pneumonia in school-aged children Sci Rep 6 223-228
[5]  
Tamura A(2008)Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children J Infect 57 1507-11
[6]  
Radisic M(2003)Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment Clin Infect Dis 31 697-728
[7]  
Torn A(2006)Clinical Features of Severe or Fatal Mycoplasma pneumoniae Pneumonia Front Microbiol 7 554-555
[8]  
Gutierrez P(2004)Mycoplasma pneumoniae and its role as a human pathogen Clin Microbiol Rev 17 110-119
[9]  
Defranchi HA(2000)Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway J Immunol 164 21-34
[10]  
Pardo P(2012)Mucins and Toll-like receptors: kith and kin in infection and cancer Cancer let 321 2193-203